Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 07 JUNE 2024

Uniform Code For Pharmaceuticals Marketing Practices 2024: Navigating Ethical Horizons

Ernst & Young
Explore more from Ernst & Young

In an ever-evolving landscape of pharmaceutical marketing, transparency, integrity, and accountability stand as the guiding stars. Striking a balance between reaching healthcare professionals...

IndiaCorporate/Commercial Law
Suresh Subramanian
Suresh Subramanian
Versha Goenka
Versha Goenka
Akshee Naruka
Akshee Naruka
Author LinkedIn connections

In an ever-evolving landscape of pharmaceutical marketing, transparency, integrity, and accountability stand as the guiding stars. Striking a balance between reaching healthcare professionals and consumers effectively while maintaining ethical practices can be challenging. Taking into consideration the problems faced by the stakeholders, the central government released the Uniform Code of Pharmaceutical Marketing Practices to be voluntarily adopted and complied by the pharma industry in 2014. In a recent development, the Uniform Code for Pharmaceutical Marketing Practices 2024 (the 'New Code') was notified by the government, under which it is now mandatory for pharma companies to comply with this code.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

CCPS In India: Why Compulsorily Convertible Preference Shares Remain Central To Venture Capital And M&A Transactions

Compulsorily Convertible Preference Shares (CCPS) remain one of the most widely used instruments for venture capital and private equity investments in Indian companies. Their appeal lies in the ability to combine equity classification with negotiated economic and governance protections. But CCPS are not governed by a single, standalone statutory framework. Their legal treatment is instead shaped by the Companies Act, FEMA and foreign investment rules, tax law, and, where applicable, SEBI regulations.
IndiaCorporate/Commercial Law
King, Stubb & Kasiva
King, Stubb & Kasiva
Article

A Sneak Peek Into A Historic Deal In The Entertainment Industry: How Paramount Beat Netflix For Warner Bros. – Lessons And Reforms For India

Chanakya, the ancient Indian strategist and author of the Arthashastra, taught that an opponent is overcome through four means: sama (persuasion), dana (inducement), bheda (division) and danda (force). The contest for Warner Bros. Discovery (WBD) is a modern illustration of all four. Netflix made the first offer and signed a merger agreement with WBD, yet Paramount played each of its cards with care.
IndiaCorporate/Commercial Law
Hammurabi & Solomon Partners
Hammurabi & Solomon Partners
Article

FCRA Amendment Rules, 2026: Key Changes And Practical Implications

AZB & Partners provides important disclaimers regarding the nature and purpose of their website, clarifying that no solicitation or advertising has occurred and that the information is provided solely at the user's request. The firm outlines the limitations of the website content and emphasizes that accessing it does not create a lawyer-client relationship. Users are informed about their responsibilities when using the site and the firm's intellectual property rights over the content.
IndiaCorporate/Commercial Law
AZB & Partners
AZB & Partners